NCT06905730Active, not recruiting
Minimal Clinically Important Difference of Clinical Test of Sensory Interaction on Balance in Individuals
Minimal Clinically Important Difference (MCID) of Clinical Test of Sensory Interaction on Balance (CTSIB) in Individuals With Sub-Acute Stroke
Source: ClinicalTrials.gov · Last updated 1 Apr 2025
Brief summary (registry, in English)
"Stroke is a major cause of disability worldwide, often leading to balance impairments due to deficits in sensory integration and motor control. These impairments hinder postural stability and functional independence, making balance rehabilitation a critical focus in sub-acute stroke care.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 100 (actual)
- First submitted
- 25 Mar 2025
- Start date
- 20 Mar 2025
- Primary completion date
- 20 Jun 2025
- Lead sponsor
- Superior University
- Diseases
- Stroke
- NCT number
- NCT06905730
What you commit to
- Study type: Observational
- Participants enrolled: 100
- From 20 Mar 2025 to the primary completion date, 20 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Participants with uncontrolled medical conditions such as cardiovascular disease or uncontrolled diabetes will not be eligible for the study.
- Individuals diagnosed with nerve compression conditions affecting motor or sensory function will be excluded.
- Patients exhibiting significant hemispatial neglect following a stroke will not be included in the study.
- Patients with gait disturbances due to conditions other than stroke (e.g., Parkinson's disease, severe arthritis) will be excluded.
Other
- Individuals with severe cognitive impairments that prevent them from understanding, consenting to, or following simple instructions will be excluded.
- Participants showing signs of unilateral spatial neglect, impacting their ability to process stimuli on one side, will be excluded.
- Patients who test positive for unilateral spatial neglect using the Catherine Line Bisection Test will be excluded.
- Individuals with severe visual impairments that compromise independent ambulation will not be eligible.
- Individuals who are unable to comply with study protocols or behavioral requirements will not be included.
Who the study is looking for
- Type of stroke Participants must have experienced a first unilateral hemispheric supratentorial stroke, which may be either ischemic or hemorrhagic in nature.
- Only individuals who have been clinically diagnosed with a stroke within the past 3 to 6 months will be included.
- Participants must have a Functional Ambulation Classification (FAC) score of 3, indicating independent ambulation with supervision or the use of a walking aid.
- The individual must have sufficient cognitive and communication abilities to understand and follow instructions during assessments.
- The study will include patients in the early subacute phase of stroke recovery, defined as 7 days to 3 months post-onset.
- Participants must have a Montreal Cognitive Assessment (MoCA) score of at least 24, indicating normal cognitive function or only mild cognitive impairment
Age in the registry: 18 years to 85 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Superior University Coordinator of this site? Confirm its status | Lahore | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.